drugset / Trial / NCT00002887
Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug is a way to kill more tumor cells. PURPOSE: Phase I trial to study the effects of hydroxyurea plus combination chemotherapy in patients with non-small cell lung cancer.
Timeline
- Start
- 1995-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxyurea | Other / unclassified | — | Oral |
| Background | Cisplatin | Other / unclassified | — | — |
| Background | Etoposide | Small molecule | — | — |
| Background | Vinblastine | Small molecule | — | — |
| Background | Vindesine | Small molecule | — | — |
| Background | Vinorelbine | Small molecule | — | — |